SAPI Board of Directors
A Board of Directors—comprising of one President, two Vice‑Presidents and nine Directors—governs the Singapore Association of Pharmaceutical Industries. Board members are normally executive officers of member firms, who are elected by the Association’s members at its general meetings.
The elected Board serves a two-year term from the date of its election.
Ms. Poh Hwee Tee
President
Country President
Novartis (Singapore) Pte Ltd
Dr. Abdullahi Sheriff
Vice-President
Managing Director
MSD Pharma (Singapore) Pte Ltd
Ms. Yeoh Ying Ying
Vice-President
General Manager
Roche Singapore Pte Ltd
Ms. Kim Suyeon
Director
Country President
AstraZeneca Singapore Pte Ltd
Mr. Reuben Ong
Director
Vice President
DKSH Singapore Pte Ltd
Ms. Celine Ting
Director
Managing Director
Eisai (Singapore) Pte Ltd
Ms. Raakhi Khera Sippy
Director
VP & General Manager, Singapore
GlaxoSmithKline Pte Ltd
Mr. Marcus Desmond
Director
General Manager
Johnson & Johnson Pte Ltd
Dr. Praful Chakkarwar
Director
Country Manager
Novo Nordisk
Ms. Quek Wee Ling
Director
General Manager
Sanofi Genzyme
Ms. Tan Yan Ann
Director
Chief Executive
Zuellig Pharma Pte Ltd
Finance & Development Committee
Ms. Tan Yan Ann
Zuellig Pharma Pte Ltd
Public Policy Committee
Dr. Abdullahi Sheriff
MSD Pharma (Singapore) Pte Ltd
Supply Chain Committee
Ms. Tan Yan Ann
Zuellig Pharma Pte Ltd
Ms Christina Teo
Executive Director
Ms Xu Meng
Public Affairs & Communications Manager
Ms Adelene Tan
Admin Executive
Ms May Wang
Accounts/Admin Executive
Membership
The Association’s membership structure comprises of Ordinary and Associate members.
Ordinary Member:
An ordinary member is any business entity involved directly in the marketing of pharmaceutical products in Singapore. Generally, these companies are research-based multinational companies involved in Research and Development of novel products, and registered to operate in Singapore.
Associate Member:
An associate member is any business entity registered in Singapore, which is engaged in the promotion and advertising of medicinal products, or in the market research, publication or other activities related to medicinal products.
